Senior Vice President, Head of Medical Affairs, Immunology & Cardiovascular

Overview

Working with Us
Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:  .

Bristol Myers Squibb (BMS) is seeking a world-class physician-executive to serve as Senior Vice President, Worldwide Head of Immunology & Cardiovascular (ICV) Medical Affairs. This leader will define and drive the global medical vision, strategy, and execution across one of BMS s most scientifically complex and strategically critical portfolios-spanning immunology, inflammation, cardiovascular disease, and cardiometabolic conditions.

This is a mission-defining enterprise role for a highly credible leader who operates seamlessly across early development through lifecycle maturity, shaping evidence, influencing global practice, and ensuring BMS delivers practice-changing, equitable impact for patients worldwide. As the senior-most medical leader for ICV, the SVP will sit on the Worldwide Medical Leadership Team, partner deeply with R&D, Commercial, Market Access, and Policy leaders, and serve as the global medical face of BMS to regulators, academia, professional societies, and patient communities.

• Enterprise & Strategic Leadership
• Define and execute an integrated global medical strategy across Immunology & Cardiovascular aligned to enterprise priorities, patient imperatives, and portfolio value creation.
• Serve as a senior enterprise advisor, shaping clinical development, regulatory strategy, evidence generation, and commercialization from early pipeline through mature brands.
• Anticipate and navigate evolving scientific, regulatory, payer, and competitive landscapes, positioning BMS as a global leader in immune-mediated and cardiovascular disease innovation.
• Contribute to portfolio strategy, prioritization, and investment decisions, including lifecycle expansion, indication strategy, and external innovation.

• Scientific & Portfolio Innovation
• Partner with R&D to shape early development strategies, including trial design, endpoints, biomarkers, and translational approaches aligned with real-world standards of care.
• Drive early signal-seeking and differentiation strategies to de-risk assets and expand pipeline and lifecycle value.
• Integrate clinical trial data, real-world evidence, and medical insights to deliver scientifically differentiated narratives that inform practice and policy.
• Support scientific diligence for external opportunities, partnerships, and acquisitions.

• Integrated Evidence Generation & Medical Strategy
• Lead the design and execution of integrated global evidence plans across the ICV portfolio-spanning interventional studies, RWE, registries, and observational research.
• Ensure evidence strategies support regulatory success, reimbursement, access, guideline inclusion, and practice change.
• Embed the patient journey and lived experience into evidence planning, ensuring relevance across diverse populations and healthcare systems.
• Partner closely with HEOR, Market Access, Clinical Development, and Commercial teams to align scientific, economic, and outcomes-based narratives.

• Operational Excellence & Outcomes
• Lead a high-performing, globally distributed medical organization, fostering a culture of accountability, scientific rigor, inclusion, and execution excellence.
• Implement globally aligned, fit-for-purpose operating models that enable speed, focus, and measurable impact.
• Leverage digital innovation, advanced analytics, and GenAI-enabled insights to elevate decision-making, insight generation, and external engagement.
• Establish outcome-based metrics to ensure medical activities deliver tangible patient, practice, and enterprise impact.

• Access, Equity & Health Systems Leadership
• Champion timely, appropriate, and equitable access to ICV therapies across major and emerging markets.
• Partner with advocacy groups, policymakers, and health systems to address disparities in immune-mediated and cardiovascular care.
• Ensure medical strategy proactively supports access pathways, including early access, real-world evidence needs, and health system readiness.

• External Leadership & Influence
• Serve as the global medical voice of BMS Immunology & Cardiovascular, engaging regulators, academic leaders, professional societies, and…